Warning! GuruFocus detected
1 Severe warning sign
with SNTI.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Senti Biosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US81726A1007
Description
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.44 | |||||
| Equity-to-Asset | 0.26 | |||||
| Debt-to-Equity | 1.31 | |||||
| Debt-to-EBITDA | -0.61 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -11.7 | |||||
| 3-Year EPS without NRI Growth Rate | 10.1 | |||||
| 3-Year FCF Growth Rate | 0.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 91.77 | |||||
| 9-Day RSI | 80.28 | |||||
| 14-Day RSI | 70.77 | |||||
| 3-1 Month Momentum % | -17.3 | |||||
| 6-1 Month Momentum % | 59.31 | |||||
| 12-1 Month Momentum % | 22.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.49 | |||||
| Quick Ratio | 4.49 | |||||
| Cash Ratio | 3.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.4 | |||||
| Shareholder Yield % | -40.67 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -126.41 | |||||
| ROA % | -56.87 | |||||
| ROIC % | -95.66 | |||||
| 3-Year ROIIC % | -556.53 | |||||
| ROC (Joel Greenblatt) % | -139.71 | |||||
| ROCE % | -73.95 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.83 | |||||
| Price-to-Tangible-Book | 0.83 | |||||
| EV-to-EBIT | -1.49 | |||||
| EV-to-EBITDA | -1.65 | |||||
| EV-to-FCF | -2.18 | |||||
| Earnings Yield (Greenblatt) % | -67.11 | |||||
| FCF Yield % | -35.95 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SNTI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Senti Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -12.03 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 85.1 | ||
| 14-Day RSI | 70.77 | ||
| 14-Day ATR ($) | 0.373113 | ||
| 20-Day SMA ($) | 3.42099 | ||
| 12-1 Month Momentum % | 22.67 | ||
| 52-Week Range ($) | 1.5201 - 16.94 | ||
| Shares Outstanding (Mil) | 26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Senti Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Senti Biosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Senti Biosciences Inc Frequently Asked Questions
What is Senti Biosciences Inc(SNTI)'s stock price today?
The current price of SNTI is $4.43. The 52 week high of SNTI is $16.94 and 52 week low is $1.52.
When is next earnings date of Senti Biosciences Inc(SNTI)?
The next earnings date of Senti Biosciences Inc(SNTI) is 2025-05-09 Est..
Does Senti Biosciences Inc(SNTI) pay dividends? If so, how much?
Senti Biosciences Inc(SNTI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers